Vaccine long‑term studies mixed
Recent threads summarize mixed evidence on long‑term effects: several studies show vaccines lower persistent COVID risks at 12 months and find no long‑term mortality signal. Other posts claim mRNA/DNA or spike protein persistence out to 3.5 years and cite registry data on lingering symptoms—causality remains unsettled in the public discourse. (x.com) (x.com) (x.com)
A national cohort of 28.7 million French adults analysed by EPI‑PHARE and published in JAMA Network Open compared 4‑year all‑cause mortality in people aged 18–59 by vaccination status and did not find an excess mortality signal in the vaccinated group. (jamanetwork.com) A March 25, 2025 ECDC literature review estimated roughly a 27% reduction in the risk of developing post‑COVID conditions for people fully vaccinated before infection, while a multicountry analysis published in The Lancet reported vaccine effectiveness against long‑COVID outcomes ranging roughly 29%–52% across the UK, Estonia and Spain. (ecdc.europa.eu) Several prospective and registry studies that include 3‑ to 12‑month follow‑ups show mixed magnitudes and depend on setting: a 12‑month prospective cohort from Aga Khan University (n≈481) reported vaccinated patients had substantially lower odds of long COVID on multivariable analysis, while STOP‑COVID registry data followed 801 patients at 3 and 12 months to track symptom trajectories. (journals.plos.org) Not all cohorts agree: an Open Forum Infectious Diseases analysis led by the Mayo Clinic recently concluded vaccination had limited effect on preventing long COVID in their study populations, illustrating heterogeneity by cohort, variant period and outcome definitions. (cidrap.umn.edu) Claims of vaccine‑derived mRNA, plasmid DNA fragments or spike protein persisting beyond three years rest largely on recent case‑level preprints — one Feb 2, 2026 preprint reported reproducible detection of vaccine‑derived material across multiple labs in a single case out to 3.5+ years — and a Feb 10, 2026 systematic review catalogued prolonged detections while stressing that mechanisms, prevalence and clinical relevance remain unresolved. (zenodo.org) Patient‑led registries and convenience samples (for example a multinational MDPI survey and Yale LISTEN analyses) have reported heterogeneous symptom changes after vaccination—percentages of respondents reporting improvement, no change or worsening vary—but those study designs and selection biases limit causal inference, a limitation flagged in recent systematic reviews. (mdpi.com)
